Global lipid nutrition market will reach $ 17,516.6 million by 2031, growing by 7.6% annually over 2021-2031, driven by the rising prevalence of various diseases and disorders, growing awareness about benefits of consuming functional lipids, increasing disposable household income, and the surged need for plant-based nutrition source to offer vegans and vegetarians with required nutrition.Highlighted … Read more
North America lipid nutrition market is projected to grow by 7.1% annually in the forecast period and reach $5,368.8 million by 2031, driven by the rising prevalence of various diseases and disorders, growing awareness about benefits of consuming functional lipids, increasing disposable household income, and the surged need for plant-based nutrition source to offer vegans … Read more
Europe lipid nutrition market was valued at $2,073.7 million in 2021 and will grow by 6.1% annually over 2021-2031, driven by the rising prevalence of various diseases and disorders, growing awareness about benefits of consuming functional lipids, increasing disposable household income, and the surged need for plant-based nutrition source to offer vegans and vegetarians with … Read more
Asia Pacific lipid nutrition market will grow by 8.9% annually with a total addressable market cap of $42,032.4 million over 2022-2031, driven by the rising prevalence of various diseases and disorders, growing awareness about benefits of consuming functional lipids, increasing disposable household income, and the surged need for plant-based nutrition source to offer vegans and … Read more
Global ophthalmic drug delivery system market will reach $ 30,013.7 million by 2031, growing by 6.9% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms … Read more
North America ophthalmic drug delivery system market is projected to grow by 6.1% annually in the forecast period and reach $12,809.8 million by 2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand … Read more
Europe ophthalmic drug delivery system market was valued at $3,856.3 million in 2021 and will grow by 6.4% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled … Read more
Asia Pacific ophthalmic drug delivery system market will grow by 8.9% annually with a total addressable market cap of $56,139.1 million over 2022-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to … Read more
Global organ transplant diagnostics market will reach $6,072.1 million by 2031, growing by 8.8% annually over 2021-2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced devices, and the surging investment and expenditure in healthcare and diagnostics.Highlighted with 91 tables … Read more
North America organ transplant diagnostics market is projected to grow by 8.1% annually in the forecast period and reach $2,227.2 million by 2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced devices, and the surging investment and expenditure in … Read more